Page last updated: 2024-11-07

pyridyldithioethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyridyldithioethylamine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID128546
SCHEMBL ID127882
MeSH IDM0156542

Synonyms (22)

Synonym
pyridyldithioethylamine
83578-21-6
2-(pyridin-2-yldisulfanyl)ethanamine
ethanamine, 2-(2-pyridinyldithio)-
FT-0605321
SCHEMBL127882
DTXSID60232441
WGGFHAVVTPGHRD-UHFFFAOYSA-N
2-(2-(pyridin-2-yl)disulfanyl)ethylamine
2-(pyridinyldithio)ethaneamine
AKOS027321762
BCP29046
2-(2-pyridinyldisulfanyl)ethanamine;2-(pyridin-2-yldisulfanyl)ethanamine
s-(2-aminoethylthio)-2-thiopyridine
2-(pyridin-2-yldisulfanyl)ethan-1-amine
(s)-2-pyridylthio cysteamine, hci
BP-31083
2-(pyridin-2-yldisulfaneyl)ethan-1-amine
LCZC2669
PD063894
2-[(2-aminoethyl)disulfanyl]pyridine
EN300-208709
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's6 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.18 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]